Using Dalfampridine to Improve Recovery After Spinal Cord Injury
Official title: Effects of Twice-daily Dosing 4-AP on Functional Recovery After Spinal Cord Injury
Run by Shirley Ryan AbilityLab · NCT06853015 · Data updated 2026-11-12
This study is testing if the drug Dalfampridine can help people with spinal cord injuries recover better movement in their legs when combined with special training.
Quick facts
| Phase | Phase1; Phase2 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years to 85 Years |
| Sex | All |
| Enrollment | 27 (estimated) |
| Sponsor | Shirley Ryan AbilityLab Academic / other |
| Locations | 1 site (Chicago, Illinois) |
| Status | Recruiting |
| Started | February 1, 2025 |
| Main results expected | March 1, 2026 |
| Study ends | December 30, 2026 |
| Registry record updated | June 3, 2026 |
| Trial ID | NCT06853015 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are males and females aged 18-85 with spinal cord injuries at or above L2, who are at least six months post-injury and can perform small visible muscle contractions.
✕Probably not a fit
Patients with uncontrolled medical problems, significant cognitive impairments, or a history of seizures may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to enhance lower limb motor function recovery in individuals with spinal cord injury (SCI) by using the FDA-approved drug Dalfampridine (4-AP) in combination with Spike-timing-dependent plasticity (STDP) stimulation and limb training. Participants will receive either 4-AP or a placebo twice daily while undergoing targeted training to promote neuroplasticity in the corticospinal pathway. The study will explore the effects of this combined approach on motor function rehabilitation and assess physiological changes associated with training. The hypothesis is that the addition of 4-AP will further improve rehabilitation outcomes for patients with chronic SCI.
Why it matters
Potential benefit: If successful, this approach could significantly enhance motor function recovery in patients with spinal cord injuries.
How similar studies have gone: Previous studies have shown positive effects of 4-AP on sensory and motor function rehabilitation in chronic SCI, indicating potential for success with this combined approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Male and females between ages 18-85 years * SCI 6 months post injury * Spinal Cord injury at or above L2 * ASIA A, B, C, or D, complete or incomplete * The ability to perform a small visible contraction with dorsiflexion and hip flexor muscles Exclusion Criteria: * Uncontrolled medical problems including pulmonary, cardiovascular or orthopedic disease * Any history of renal impairment * Any debilitating disease prior to the SCI that caused exercise intolerance * Premorbid, ongoing major depression or psychosis, altered cognitive status * History of head injury or stroke * Vascular, traumatic, tumoral, infectious, or metabolic lesion of the brain, even without history of seizure, and without anticonvulsant medication * History of seizures or epilepsy * Receiving drugs acting primarily on the central nervous system, which lower the seizure threshold (see appendix 2) * Pregnant females * If a women of child bearing age is unsure of the pregnancy, and does not want to take the pregnancy test * Ongoing cord compression or a syrinx in the spinal cord or who suffer from a spinal cord disease such as spinal stenosis, spina bifida, MS, or herniated disk * Metal plate in skull * Individuals with scalp shrapnel, cochlear implants, or aneurysm clips * Individuals taking Bupropion, Dolutegravir, Lacosamide, Trilaciclib, or PR Interval prolonging drugs
Where it's running
-
Shirley Ryan Abilitylab
Chicago, Illinois, United States Recruiting
Study contacts
- Principal investigator: Monica Perez, PT, PhD — Shirley Ryan Ability Lab
- Study coordinator: Monica Perez, PT, PhD
- Email: mperez04@sralab.org
- Phone: 312-238-2886
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Targeted spinal cord stimulation to reduce spasticity in spinal cord injury
This study tests whether an implanted epidural stimulator can help reduce severe spasticity and improve voluntary movement in adults with spinal cord injury.
-
Spinal cord stimulation for bladder and bowel problems after spinal cord injury
This project will test spinal cord stimulation to see if it helps people with bladder and bowel problems after a spinal cord injury.
-
Home-based passive heat therapy to improve cardiovascular health after spinal cord injury
This program will test whether regular passive heat sessions at home can improve blood vessel and heart health in adults with chronic spinal cord injury.
-
ARC-IM therapy to help restore walking after spinal cord injury
This study will try ARC-IM Therapy (epidural electrical stimulation) in adults with subacute or chronic traumatic spinal cord injury to see if it helps improve walking and other ambulatory functions.
-
Near-infrared imaging to see how motor imagery affects recovery after spinal cord injury
This trial will test whether a motor-imagery brain-computer interface (MI-BCI) can help adults with recent cervical-to-thoracic spinal cord injuries improve motor function and change brain activity measured by fNIRS and EEG.
-
How different meals affect metabolism and heat production after high spinal cord injury
This study will see if different meal sizes change heart and metabolic responses in men with and without high spinal cord injury.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.